Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, May 15, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Grants Advanced Therapy Designation to BrainChild Bio’s CAR T-Cell Treatment for Pediatric Brain Cancer
Life Sciences Times
-
May 15, 2025
Pharma
MassBio Pushes Back Against ‘Most Favored Nation’ Drug Pricing Policy Following Executive Order
Life Sciences Times
-
May 14, 2025
Pharma
Sensory Cloud Completes Enrollment for Phase 2a Trial Targeting Refractory Chronic Cough
Life Sciences Times
-
May 14, 2025
Pharma
Faeth Therapeutics Publishes Preclinical Data Supporting Drug-Diet Combo for Metabolism-Driven Cancers
Life Sciences Times
-
May 14, 2025
Pharma
GSK Acquires Phase III-Ready Efimosfermin to Advance Liver Disease Treatment Portfolio
Life Sciences Times
-
May 14, 2025
Pharma
Glycomine Announces First Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG
Life Sciences Times
-
January 9, 2023
0
Pharma
Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1
Life Sciences Times
-
January 9, 2023
0
Pharma
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma
Life Sciences Times
-
January 5, 2023
0
Pharma
PharmaEssentia Establishes a New Research and Development Facility in the Boston Area
Life Sciences Times
-
January 4, 2023
0
Pharma
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Life Sciences Times
-
January 3, 2023
0
Pharma
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
Life Sciences Times
-
December 22, 2022
0
Pharma
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
Life Sciences Times
-
December 21, 2022
0
Pharma
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Life Sciences Times
-
December 21, 2022
0
Pharma
Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or...
Life Sciences Times
-
December 20, 2022
0
Pharma
Massachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic...
Life Sciences Times
-
December 16, 2022
0
Pharma
Thea Pharma Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension
Life Sciences Times
-
December 15, 2022
0
Pharma
Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol
Life Sciences Times
-
December 14, 2022
0
1
...
17
18
19
...
64
Page 18 of 64
Most Read
Organogenesis Expands Operations with Full-Building Lease at Smithfield Biomanufacturing Facility
May 15, 2025
COPE Health Solutions Appoints Dr. Richard Petrucci as Chief Medical Officer to Strengthen Clinical Leadership in Value-Based Care
May 15, 2025
Iodine Software Unveils Advanced Pre-Bill AI Tool to Help Hospitals Recover Lost Revenue
May 15, 2025
Datavant to Acquire Aetion in Major Move to Expand Real-World Evidence Capabilities for Healthcare and Life Sciences
May 15, 2025